{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:07:35Z","timestamp":1780103255833,"version":"3.54.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006790","name":"University of Michigan College of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118643","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:51:21Z","timestamp":1775494281000},"page":"118643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis"],"prefix":"10.1016","volume":"138","author":[{"suffix":"II","given":"Timothy J.","family":"Borel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob R.","family":"Hitchens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hargobinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vern B.","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Clasby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118643_bb0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4269\/ajtmh.17-0677","article-title":"Toxoplasma gondii infection in the United States, 2011\u20132014","volume":"98","author":"Jones","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmc.2026.118643_bb0010","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","article-title":"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens","volume":"75","author":"Hoffmann","year":"2012","journal-title":"J Food Prot"},{"key":"10.1016\/j.bmc.2026.118643_bb0015","doi-asserted-by":"crossref","unstructured":"Dubey, J. P. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol vol. 39 877\u2013882 Preprint at doi:https:\/\/doi.org\/10.1016\/j.ijpara.2009.01.005 (2009).","DOI":"10.1016\/j.ijpara.2009.01.005"},{"key":"10.1016\/j.bmc.2026.118643_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1863-2378.2009.01276.x","article-title":"A brief history and overview of toxoplasma gondii","volume":"57","author":"Innes","year":"2010","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.bmc.2026.118643_bb0025","first-page":"147","article-title":"Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome","volume":"41","author":"Lanjewar","year":"1998","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.bmc.2026.118643_bb0030","doi-asserted-by":"crossref","unstructured":"Nascimento, F. S. et al. Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders. Schizophr Res vol. 142 244\u2013245 Preprint at doi:https:\/\/doi.org\/10.1016\/j.schres.2012.08.036 (2012).","DOI":"10.1016\/j.schres.2012.08.036"},{"key":"10.1016\/j.bmc.2026.118643_bb0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biopsych.2012.01.003","article-title":"The relationship between toxoplasma gondii infection and mood disorders in the third national health and nutrition survey","volume":"72","author":"Pearce","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bmc.2026.118643_bb0040","first-page":"31","article-title":"Management of toxoplasmic encephalitis in HIV-infected adults--a review","volume":"98","author":"Dedicoat","year":"2008","journal-title":"S Afr Med J"},{"key":"10.1016\/j.bmc.2026.118643_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111711","article-title":"Recent progress on anti-toxoplasma drugs discovery: design, synthesis and screening","volume":"183","author":"Deng","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118643_bb0050","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1365-2958.2010.07181.x","article-title":"Cathepsin l occupies a vacuolar compartment and is a protein maturase within the endo\/exocytic system of toxoplasma gondii","volume":"76","author":"Parussini","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2026.118643_bb0055","doi-asserted-by":"crossref","unstructured":"McDonald, C. et al. Toxoplasma cathepsin protease b and aspartyl protease 1 are dispensable for endolysosomal protein digestion. mSphere 5, (2020).","DOI":"10.1128\/mSphere.00869-19"},{"key":"10.1016\/j.bmc.2026.118643_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.01011-24","article-title":"Metabolic adaptability and nutrient scavenging in toxoplasma gondii: insights from ingestion pathway-deficient mutants","volume":"10","author":"Rimple","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.bmc.2026.118643_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01188-14","article-title":"Toxoplasma gondii ingests and digests host cytosolic proteins","volume":"5","author":"Dou","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.bmc.2026.118643_bb0070","doi-asserted-by":"crossref","first-page":"17096","DOI":"10.1038\/nmicrobiol.2017.96","article-title":"Toxoplasma depends on lysosomal consumption of autophagosomes for persistent infection","volume":"2","author":"Di Cristina","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2026.118643_bb0075","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1074\/jbc.M109.003780","article-title":"Toxoplasma gondii cathepsin l is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl","volume":"284","author":"Larson","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118643_bb0080","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/acschemneuro.9b00674","article-title":"Discovery and optimization of triazine nitrile inhibitors of toxoplasma gondii cathepsin l for the potential treatment of chronic toxoplasmosis in the CNS","volume":"11","author":"Zwicker","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118643_bb0085","unstructured":"Molecular Operating Environment (MOE), 2024.0601 Chemical Computing Group ULC, 910\u20131010 Sherbrooke St. W., Montreal, QC H3A 2R7, 2025."},{"key":"10.1016\/j.bmc.2026.118643_bb0090","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.bmcl.2009.05.071","article-title":"Dipeptidyl nitrile inhibitors of cathepsin l","volume":"19","author":"Asaad","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118643_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cmdc.201600563","article-title":"Inhibition of the cysteine protease human cathepsin\u00a0L by triazine nitriles: amide\u00b7\u00b7\u00b7heteroarene \u03c0-stacking interactions and chalcogen bonding in the s3 pocket","volume":"12","author":"Giroud","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118643_bb0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bmc.2026.118643_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21010075","article-title":"Chemical structure-related drug-like criteria of global approved drugs","volume":"21","author":"Mao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118643_bb0110","doi-asserted-by":"crossref","unstructured":"Grygorenko, O. O., Melnykov, K. P., Holovach, S. & Demchuk, O. Fluorinated cycloalkyl building blocks for drug discovery. ChemMedChem vol. 17 Preprint at doi:https:\/\/doi.org\/10.1002\/cmdc.202200365 (2022).","DOI":"10.1002\/cmdc.202200365"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:44:21Z","timestamp":1780101861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"alternative-id":["S0968089626000994"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118643","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118643"}}